Advertisement
Advertisement

LGVN

LGVN logo

Longeveron Inc. Common Stock

0.80
USD
Sponsored
+0.04
+5.26%
Jun 03, 16:00 UTC -4
Closed
exchange

After-Market

0.78

-0.02
-2.50%

Longeveron Inc. Common Stock Profile

About

Longeveron Inc. is a clinical stage biotechnology company. It engages in developing cellular therapies for chronic aging-related and life-threatening conditions. The company's investigational product includes LOMECEL-B(TM). Longeveron Inc. is based in MIAMI.

Info & Links

CEO

Stephen H. Willard

Headquarters

1951 NW 7TH AVENUE, SUITE 520
MIAMI, FL 33136, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://longeveron.com

Auditor

CBIZ CPAs P.C.

Share holders

30

Employees

38

Longeveron Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

24.65M

Enterprise Value

9.67M

Enterprise Value/EBITDA(ttm)

-0.44

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

21.54

Price to Book(mrq)

4.48

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

70.01%

Operating Margin(ttm)

-1893.58%

Profit Margin(ttm)

-2417.17%

Return on Equity(ttm)

-199.79%

Return on Invested Capital(ttm)

-234.55%

Return on Assets(ttm)

-143.21%

Income Statement

Revenue(ttm)

1.22M

Revenue Per Share(ttm)

0.04

Gross Profit(ttm)

792.00K

EBITDA(ttm)3

-21.82M

Net Income Available to Common(ttm)

-22.43M

Diluted EPS(ttm)

-1.28

Share Statistics

Beta (5Y Monthly)

-0.18

52-Week Change

-36.00%

S&P 500 52-Week Change

26.51%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

31.15M

Dividend Yield

0.00%

Float4

20.66M

% Held by Insiders

11.20%

% Held by Institutions

10.01%

Balance Sheet

Total Cash(mrq)

15.76M

Total Cash Per Share(mrq)

0.51

Total Debt(mrq)

778.00K

Total Debt/Equity(mrq)

2.98%

Current Ratio(mrq)

1.33%

Quick Ratio(mrq)

1.33%

Book Value Per Share(mrq)

0.25

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.06

Free Cash Flow(ytd)

-18.89M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement